146 related articles for article (PubMed ID: 37936677)
21. Extracellular calcium increases CXCR4 expression on bone marrow-derived cells and enhances pro-angiogenesis therapy.
Wu Q; Shao H; Darwin ED; Li J; Li J; Yang B; Webster KA; Yu H
J Cell Mol Med; 2009 Sep; 13(9B):3764-73. PubMed ID: 19220581
[TBL] [Abstract][Full Text] [Related]
22. Highly Efficient Generation of Transgenically Augmented CAR NK Cells Overexpressing CXCR4.
Jamali A; Hadjati J; Madjd Z; Mirzaei HR; Thalheimer FB; Agarwal S; Bonig H; Ullrich E; Hartmann J
Front Immunol; 2020; 11():2028. PubMed ID: 32983147
[TBL] [Abstract][Full Text] [Related]
23. CXCR4 blockade improves leukemia eradication by allogeneic lymphocyte infusion.
Jin CH; Li Y; Xia J; Li Y; Chen M; Hu Z; Mapara MY; Li W; Yang YG
Am J Hematol; 2018 Jun; 93(6):786-793. PubMed ID: 29603337
[TBL] [Abstract][Full Text] [Related]
24. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury.
Tögel F; Isaac J; Hu Z; Weiss K; Westenfelder C
Kidney Int; 2005 May; 67(5):1772-84. PubMed ID: 15840024
[TBL] [Abstract][Full Text] [Related]
25. Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms.
Yang J; Kumar A; Vilgelm AE; Chen SC; Ayers GD; Novitskiy SV; Joyce S; Richmond A
Cancer Immunol Res; 2018 Oct; 6(10):1186-1198. PubMed ID: 30108045
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of the chemokine receptor CXCR4.
Luo J; De Pascali F; Richmond GW; Khojah AM; Benovic JL
J Biol Chem; 2022 Feb; 298(2):101551. PubMed ID: 34973340
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1).
Möhle R; Failenschmid C; Bautz F; Kanz L
Leukemia; 1999 Dec; 13(12):1954-9. PubMed ID: 10602415
[TBL] [Abstract][Full Text] [Related]
28. The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow.
Shen W; Bendall LJ; Gottlieb DJ; Bradstock KF
Exp Hematol; 2001 Dec; 29(12):1439-47. PubMed ID: 11750103
[TBL] [Abstract][Full Text] [Related]
29. Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells.
Kalinkovich A; Tavor S; Avigdor A; Kahn J; Brill A; Petit I; Goichberg P; Tesio M; Netzer N; Naparstek E; Hardan I; Nagler A; Resnick I; Tsimanis A; Lapidot T
Cancer Res; 2006 Nov; 66(22):11013-20. PubMed ID: 17108140
[TBL] [Abstract][Full Text] [Related]
30. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma.
Geminder H; Sagi-Assif O; Goldberg L; Meshel T; Rechavi G; Witz IP; Ben-Baruch A
J Immunol; 2001 Oct; 167(8):4747-57. PubMed ID: 11591806
[TBL] [Abstract][Full Text] [Related]
31. Engineering lymph node homing of ex vivo-expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7.
Somanchi SS; Somanchi A; Cooper LJ; Lee DA
Blood; 2012 May; 119(22):5164-72. PubMed ID: 22498742
[TBL] [Abstract][Full Text] [Related]
32. CXCR4-CXCL12 interaction is important for plasma cell homing and survival in NZB/W mice.
Cheng Q; Khodadadi L; Taddeo A; Klotsche J; F Hoyer B; Radbruch A; Hiepe F
Eur J Immunol; 2018 Jun; 48(6):1020-1029. PubMed ID: 29427452
[TBL] [Abstract][Full Text] [Related]
33. The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression.
Kuo YY; Hou HA; Chen YK; Li LY; Chen PH; Tseng MH; Huang CF; Lee FY; Liu MC; Liu CW; Chou WC; Liu CY; Tang JL; Yao M; Tien HF
Haematologica; 2014 Dec; 99(12):1799-807. PubMed ID: 25193961
[TBL] [Abstract][Full Text] [Related]
34. Pattern of expression of CXCR4 and adhesion molecules by human CD34+ cells from different sources: role in homing efficiency in NOD/SCID mice.
Herrera C; Sanchez J; Torres A; Pascual A; Rueda A; Alvarez MA
Haematologica; 2004 Sep; 89(9):1037-45. PubMed ID: 15377464
[TBL] [Abstract][Full Text] [Related]
35. Improved Antitumor Effect of NK Cells Activated by Neutrophils in a Bone Marrow Transplant Model.
Nakato D; Iwamoto S; Amano K; Ito T; Toyoda H; Hanaki R; Morimoto M; Niwa K; Tawara I; Imanaka-Yoshida K; Ogawa M; Hirayama M
Mediators Inflamm; 2023; 2023():6316581. PubMed ID: 36762286
[TBL] [Abstract][Full Text] [Related]
36. Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model.
Kyriakou C; Rabin N; Pizzey A; Nathwani A; Yong K
Haematologica; 2008 Oct; 93(10):1457-65. PubMed ID: 18728032
[TBL] [Abstract][Full Text] [Related]
37. CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions.
Eash KJ; Means JM; White DW; Link DC
Blood; 2009 May; 113(19):4711-9. PubMed ID: 19264920
[TBL] [Abstract][Full Text] [Related]
38. Physiology of natural killer cells. In vivo regulation of progenitors by interleukin 3.
Kalland T
J Immunol; 1987 Dec; 139(11):3671-5. PubMed ID: 3500227
[TBL] [Abstract][Full Text] [Related]
39. [Homing characteristics of graft cells in leukemia mice after allogenic bone marrow transplantation with different conditioning regimens].
Chen CP; Chen ZZ; Huang HF; Cai XY; He HX; Wu ZC; Luo XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):137-41. PubMed ID: 22391184
[TBL] [Abstract][Full Text] [Related]
40. An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination.
Pallarès V; Unzueta U; Falgàs A; Sánchez-García L; Serna N; Gallardo A; Morris GA; Alba-Castellón L; Álamo P; Sierra J; Villaverde A; Vázquez E; Casanova I; Mangues R
J Hematol Oncol; 2020 Apr; 13(1):36. PubMed ID: 32295630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
